Today: 9 June 2026
EchoStar Stock in Focus After FCC Approves $40 Billion Spectrum Plan
18 May 2026
2 mins read

EchoStar Stock in Focus After FCC Approves $40 Billion Spectrum Plan

New York, May 18, 2026, 05:02 (EDT)

  • EchoStar finished at $137.23, gaining 1.57%. The move came after the FCC cleared its spectrum sales to AT&T and SpaceX.
  • The deals could help with balance-sheet stress, but the $2.4 billion escrow requirement is still a risk.
  • Investors are watching weak pay-TV trends and EchoStar’s “going concern” warning.

EchoStar is trading around last week’s highs in U.S. pre-market hours Monday after regulators approved its near $40 billion wireless spectrum sale to AT&T and SpaceX. The Dish parent has become a standout trade in telecom after the deal. Spectrum refers to licensed airwaves for wireless signals.

Nasdaq’s pre-market session is open from 4:00 a.m. to 9:30 a.m. Eastern in New York, with regular trading set to kick off at 9:30 a.m. For now, Friday’s close remains the standard reference before today’s open.

EchoStar finished Friday at $137.23, up $2.12, or 1.57%, with around 5.46 million shares trading hands, company data said. Shares gained every day from Tuesday to Friday after the FCC move. Friday’s intraday top hit $139.00, just shy of Thursday’s $139.54.

FCC’s clearance cuts out a big regulatory snag from a rescue plan that’s based on selling spectrum instead of pushing for a full-scale national wireless rollout. AT&T is set to pay $23 billion for about 50 megahertz of airwaves. SpaceX is picking up 65 megahertz for $17 billion, aiming to power direct-to-device links for Starlink, connecting satellites straight to phones.

EchoStar is “THE SpaceX play, for now,” New Street Research analyst Pierre Ferragu said in a note cited by Investing.com. Ferragu said the SpaceX valuation priced into EchoStar shares “looks low vs. reported IPO values.” New Street gave EchoStar a buy and a $161 price target last week. Investing.com

Shift in US wireless competition. AT&T has picked up spectrum for 5G capacity, as Verizon, AT&T and T-Mobile said Thursday they’re planning a joint venture to tackle rural “dead zones” with direct-to-device satellite. Analysts in a Reuters report called that a possible defensive move as SpaceX moves into wireless coverage.

EchoStar posted weaker results for the first quarter, with revenue at $3.67 billion compared to $3.87 billion last year. Net loss attributable to EchoStar came in at $146.9 million. The company lost about 366,000 pay-TV subscribers, but added around 16,000 retail wireless subscribers.

EchoStar’s risk now centers on deal closing, not TV subs. In its 10-Q, the company said funding from AT&T and SpaceX deals doesn’t count as committed until the deals close. It said it hasn’t got enough cash, expected cash flow, or committed financing to cover obligations for at least a year, raising “substantial doubt” about its ability to keep operating as a going concern — the standard accounting signal for business survival troubles. SEC

FCC OK’d the deal but said EchoStar has to put $2.4 billion into escrow to cover possible claims about network builds or similar disputes. EchoStar called the escrow demand “unprecedented” and said it’s still figuring out what to do. Light Reading

Court action is possible but probably not coming, New Street’s Blair Levin, a former FCC official, told Light Reading. “The spectrum saga is not over,” Levin wrote. But he said a legal challenge to the transfer isn’t likely. LightShed Partners analysts Walter Piecyk and Joe Galone sounded less sure: “We doubt that is the last word from Ergen,” they said. Light Reading

Looking to the coming week, investors are waiting to see if EchoStar gives an update on the escrow, if tower and infrastructure lawsuits start to intensify, and if pre-market interest actually turns into action after Friday’s move. Bulls point to the FCC approval, calling it a step toward getting cash and tying the company to SpaceX. But the risks are clear too: delays, legal trouble, or bigger claims could push the focus back onto EchoStar’s balance sheet.

Stock Market Today

  • IREN Stock Nears $60 on AI Data-Center Expansion, Bitcoin Rebound
    June 9, 2026, 9:55 AM EDT. IREN Limited shares rose 8.9% to $59.19 on Monday, nearing $60 ahead of Tuesday's Nasdaq open amid a bitcoin rebound and a strategic pivot to AI cloud infrastructure. The stock, known for volatility, reflects uncertainty whether it will trade more like a bitcoin miner or an AI cloud operator. IREN plans an 800-megawatt data-center campus in South Australia, supported by clean energy, targeting 2028 energisation and generating substantial jobs. The firm recently secured a $3.4 billion, five-year AI cloud contract with Nvidia and maintains $3.1 billion in annualized run-rate revenue from existing contracts. Despite these developments, risks remain from bitcoin price swings, funding requirements, and data-center construction delays.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Destiny Tech100 Gains Pre-Market as SpaceX IPO Buzz Mixes With AI Stock Warnings
Previous Story

Destiny Tech100 Gains Pre-Market as SpaceX IPO Buzz Mixes With AI Stock Warnings

HIVE stock gains after $3.5 billion AI facility news
Next Story

HIVE stock gains after $3.5 billion AI facility news

Go toTop